Analysis of Medication Compliance on Endocrine Therapy in 280 Breast Cancer Patients
10.6039/j.issn.1001-0408.2016.26.39
- VernacularTitle:280例乳腺癌患者内分泌治疗用药依从性分析
- Author:
Juan DU
;
Xiuli ZHAO
;
Wenzhou ZHANG
- Publication Type:Journal Article
- Keywords:
Clinical pharmacists;
Breast cancer;
Endocrine therapy;
Medication compliance
- From:
China Pharmacy
2016;27(26):3718-3720
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for improving the breast cancer patients’medication compliance. METHODS:280 inpatients with advanced breast cancer who had received endocrine therapy in a hospital ward of chemotherapy of breast from Sept. to Nov. 2015 were selected,questionnaires was combined with on-site interview to investigate and analyze the medication com-pliance,influential factors and adverse reactions induced by endocrine drugs. RESULTS:Among the 280 patients,161 (57.5%) showed good medication compliance,64(22.9%)were general and 55(19.6%)were poor;its medication compliance were mainly affected by“wrong understanding on disease control (27.2%)”“adverse drug reactions (22.4%)”“forgetting taking medicines (21.1%)”;the common adverse reactions of endocrine therapy included hot flashes,mood disorders and joint pain. CONCLU-SIONS:Clinical pharmacists,especially the specialists should give full play to their own professional advantage,strengthen patient medication education,actively participate ward round and follow-up,improve breast cancer patients’compliance on endocrine therapy.
